LEDRU PHILIPPE 4
4 · Aptose Biosciences Inc. · Filed Feb 7, 2024
Insider Transaction Report
Form 4
LEDRU PHILIPPE
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-02-05+11,000→ 11,000 totalExercise: $2.00Exp: 2034-02-05→ Common Shares (11,000 underlying)
Footnotes (1)
- [F1]50% of the options vest on February 5, 2025, with the remaining options vesting as follows: 1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028.